Citigroup’s Core Laboratories CLB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q4
Sell
-300
Closed -$5K 7392
2020
Q3
$5K Sell
300
-2,700
-90% -$56.6K ﹤0.01% 6987
2020
Q2
$61K Buy
3,000
+1,200
+67% +$21.5K ﹤0.01% 5902
2020
Q1
$19K Buy
1,800
+800
+80% +$22.4K ﹤0.01% 6719
2019
Q4
$38K Buy
1,000
+800
+400% +$35.9K ﹤0.01% 6526
2019
Q3
$9K Sell
200
-9,800
-98% -$456K ﹤0.01% 7113
2019
Q2
$523K Buy
10,000
+9,200
+1,150% +$540K ﹤0.01% 4374
2019
Q1
$55K Sell
800
-2,000
-71% -$134K ﹤0.01% 6256
2018
Q4
$167K Sell
2,800
-1,800
-39% -$155K ﹤0.01% 5201
2018
Q3
$533K Sell
4,600
-100
-2% -$11.3K ﹤0.01% 4201
2018
Q2
$593K Buy
4,700
+2,600
+124% +$316K ﹤0.01% 3908
2018
Q1
$227K Sell
2,100
-2,900
-58% -$321K ﹤0.01% 4837
2017
Q4
$548K Sell
5,000
-1,100
-18% -$110K ﹤0.01% 4004
2017
Q3
$602K Buy
6,100
+5,800
+1,933% +$562K ﹤0.01% 3919
2017
Q2
$30K Buy
300
+200
+200% +$21.6K ﹤0.01% 6084
2017
Q1
$12K Sell
100
-2,500
-96% -$291K ﹤0.01% 6488
2016
Q4
$312K Buy
2,600
+1,500
+136% +$166K ﹤0.01% 4886
2016
Q3
$124K Buy
+1,100
New +$127K ﹤0.01% 5047
2015
Q4
Sell
-400
Closed -$40K 7584
2015
Q3
$40K Buy
+400
New +$43.5K ﹤0.01% 5576

Other funds holding CLB

Citigroup's CLB Position: Q1 2026 in Review

Citigroup increased its Core Laboratories (CLB) stake by 174% in Q1 2026, buying an estimated $317K and bringing the position to 27,905 shares worth $469K. The position accounts for ﹤0.01% of the portfolio, ranked #3590.

Citigroup first reported a position in CLB in Q2 2013 and has held it in 52 quarters since. The position peaked at $15.9M in Q2 2018. 190 funds tracked by Wall St. Rank hold CLB as of Q1 2026.

  • Citigroup held 27,905 shares of Core Laboratories worth $469K as of Q1 2026.
  • Citigroup bought 17,709 Core Laboratories shares in Q1 2026, an estimated $317K.
  • Core Laboratories made up ﹤0.01% of Citigroup's portfolio in Q1 2026, its #3590 holding.
  • Citigroup first reported a position in Core Laboratories in Q2 2013 and has held it in 52 quarters since.
  • Citigroup's Core Laboratories position peaked at $15.9M in Q2 2018.
  • 190 funds tracked by Wall St. Rank held Core Laboratories as of Q1 2026.

Based on Citigroup's 13F filing for Q1 2026, filed 11 May 2026.